Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Product/Service, Webcast

MiLaboratories Introduces Platforma Bio: A Revolutionary UI-First Computational Biology Platform powered by AI


MiLaboratories, a leader in developing best-in-class software for immunological data analysis, proudly announces the official launch of Platforma.bio. This groundbreaking computational biology platform, powered by AI large language models, is designed to significantly streamline, and simplify biological analysis, making it more accessible to researchers across various disciplines.

Stan Poslavsky, CEO of MiLaboratories, emphasizes, "At MiLaboratories, our focus is on creating sophisticated yet user-friendly tools that facilitate the analysis of next generation sequencing data. Platforma.bio represents a major leap forward in achieving this goal, offering a UI-first approach that transforms complex processes into manageable, easy-to-combine blocks."

Platforma.bio stands out in the computational biology field with its unique, patent-pending engine that effectively identifies and eliminates redundant computations. This innovation not only promotes iterative workflows but also ensures the flexible offloading of computations to remote clusters, clouds, or powerful servers, optimizing both computational and storage resources.

Key features and benefits of Platforma.bio include:

MiLaboratories has established partnerships with industry leaders such as Illumina, further strengthening its position in the computational biology market. These collaborations underscore MiLaboratories' commitment to delivering cutting-edge solutions to the research community.

Platforma.bio is available for free to academic and non-profit organizations. Comprehensive customer support, including extended options, is readily accessible to ensure users can fully leverage the platform's capabilities.

To introduce Platforma.bio to the research community, MiLaboratories will host a detailed webinar showcasing its features and practical applications. Interested parties are encouraged to visit https://platforma.bio for further information and to register for the event.

About MiLaboratories: MiLaboratories is at the forefront of developing state-of-the-art software solutions for immunological data analysis. The company is dedicated to enhancing the capabilities of researchers and clinicians by providing advanced, user-friendly tools designed to streamline complex biological data analysis processes.


These press releases may also interest you

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

at 18:46
BOXABL, the innovative housing startup known for its foldable Casita homes and building technology, has announced this week that investors have indicated they want to invest over $10MM in the current stock offering. BOXABL previously SOLD OUT the Reg...

at 18:40
Today, a federal court ruled for Ryan (a leading global tax services and software provider) and against the U.S. Federal Trade Commission (FTC), halting the FTC's ban on non-compete agreements set to take effect this fall. U.S. District Court Judge...

at 17:45
The global automotive battery testers market  size is estimated to grow by USD 78.9 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 3.73%  during the forecast period.  Increasing lifespan of...



News published on and distributed by: